Cardio Diagnostics Holdings, Inc. Logo

Cardio Diagnostics Holdings, Inc.

Develops AI-powered epigenetic and genetic tests for early heart disease detection.

CDIO | US

Overview

Corporate Details

ISIN(s):
US56168P2039 (+2 more)
LEI:
Country:
United States of America
Address:
311 W. SUPERIOR STREET, 60645 CHICAGO

Description

Cardio Diagnostics Holdings, Inc. is a biotechnology company specializing in the development and commercialization of clinical tests for cardiovascular disease. The company leverages a proprietary platform that integrates artificial intelligence with epigenetics and genetics to enable early detection and prevention of heart disease. Its primary products are blood-based tests, including Epi+Gen CHD and PrecisionCHD™, which assess a patient's risk for coronary heart disease. These diagnostic tools analyze an individual's unique genetic and epigenetic markers to provide personalized insights, aiming to make cardiovascular care more precise and accessible for clinicians and patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Cardio Diagnostics Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardio Diagnostics Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cardio Diagnostics Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Avalo Therapeutics, Inc. Logo
Clinical-stage biotech developing treatments for immune-mediated inflammatory diseases.
United States of America
AVTX
Azenta, Inc. Logo
Offers sample management, storage, and multiomics solutions for life sciences.
United States of America
AZTA
BenevolentAI Logo
Applies artificial intelligence to accelerate drug discovery and development.
United Kingdom
BAI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics and targeted therapeutics for cancer.
United States of America
BIAF
BioArctic Logo
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
Sweden
BIOA
BioInfra Co.,Ltd. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
199730
BioInfra Life Science Inc. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
266470
BioNexus Gene Lab Corp Logo
Develops gene-based diagnostics for early detection of disease susceptibility.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
France
ALBPS
BioRestorative Therapies, Inc. Logo
Develops adult stem cell therapies for degenerative disc and metabolic disorders.
United States of America
BRTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.